Semaglutide Injection for Weight Loss
A GLP-1 receptor agonist that works with your body's appetite and blood-sugar signaling to support weight management.
- Appetite signaling — less mental noise around food
- Weight management alongside nutrition and strength work
- Steadier blood-sugar signaling
- Live visit with a licensed clinician
- Medication delivered to your home, if prescribed
- Medication included in the price, with no separate medication fee
- Subscription, cancel anytime
Indicative price · confirmed after eligibility · prescription treatment
How it works, and what that feels like
Semaglutide has the longest clinical track record of the GLP-1 medications, which is the main reason it is where most people start.
It is also the one most surrounded by noise — miracle framing on one side, dismissal on the other. What follows is neither: what it does, what it actually feels like, who it suits, and what happens when you stop.
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut already releases after eating; it signals fullness to the brain, slows how quickly the stomach empties, and helps regulate the insulin response to a meal. The medication works with that existing system rather than overriding it. If you are curious about the biology, GLP-1s are peptides covers it.
A word on names. Semaglutide is the molecule in Ozempic, Wegovy and Rybelsus, which are FDA-approved branded medications. Compounded semaglutide is none of them: it is prepared by a licensed compounding pharmacy, it is not FDA-approved, and it is not equivalent to or interchangeable with any of those brands. Ozempic, Wegovy and Rybelsus explained covers what separates the three.
The subjective experience is worth describing, because it is not what most people expect.
It is not willpower arriving. It is more that the background noise quietens. The mental loop that returns to food several times an hour tends to fade, and meals finish sooner because you are full sooner. People often describe it as food occupying less space in their head — which is a different thing from wanting food and resisting it.
That distinction matters for two reasons. If you were expecting a stimulant-like effect, this will not feel like that. And if you have spent years being told your weight was a discipline problem, discovering that the difficulty was partly biological is a genuinely significant reframe. Many people find that the more useful part.
Semaglutide is a GLP-1 receptor agonist. It works with the body's own appetite and blood-sugar signaling as part of a structured, clinician-monitored plan. The semaglutide prescribed through ACT 2 Health is prepared by a licensed compounding pharmacy. It is not an FDA-approved product, and it is not the same as, equivalent to, or interchangeable with any branded medication.
How it works here
Every plan follows one path. Each step feeds the next. See the Medical Weight Loss approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Injection, capsule, or your own insurance?
The molecule is the same; the delivery and the economics differ.
On the compounding question specifically, see compounded semaglutide vs Wegovy.
The honest summary: if your insurance covers a branded GLP-1, check that first. The membership lets you obtain the branded medication through your own benefit and pay us only for the clinical care around it — frequently the better structure, and we would rather tell you that than sell you something you could get covered.
Branded semaglutide is now also sold for cash directly by its manufacturer; current branded cash prices are on our cost page.
Choosing between semaglutide and tirzepatide is a separate question, and a clinical one. Neither is better as a general matter, and we do not publish comparative outcome figures for compounded medications.
The part almost nobody covers: GLP-1s and menopause
If you are a woman in your forties or fifties who feels like her body changed the rules, this section is the reason this page exists.
Weight change through perimenopause and menopause is not the same problem as weight change at thirty. Falling estrogen shifts fat toward the abdomen, alongside declining muscle mass, disrupted sleep and, often, a metabolic picture that has quietly moved. The strategy that worked before frequently stops working, and it is not because you stopped trying.
A GLP-1 can help, and it is not the whole answer. It addresses appetite and metabolic signaling, not the hormonal shift underneath, and treating one while ignoring the other is a common route to a disappointing result.
These conversations belong together. Hormone therapy and weight management are usually handled at different clinics; ours are the same conversation, so expect to be asked about sleep, hot flashes and cycle changes too. See menopause and perimenopause care, and for the stage-by-stage detail, semaglutide and menopause.
Who it is for — and the cutoff we do not use
Semaglutide is considered for adults in midlife carrying weight that resists lifestyle change.
There is no blanket BMI cutoff. Eligibility is assessed case by case, on your symptoms, your metabolic picture and your history. A single threshold captures none of what actually drives midlife weight change, which is why we measure first — thyroid function, insulin, and hormones frequently explain more than the scale does.
After 60 the assessment changes in three specific ways — see semaglutide after 60.
What to expect, and what to watch for
Side effects are mostly gastrointestinal, nausea most commonly, and often ease with careful adjustment by your clinician over time. Telling us early matters — most of the time the plan can be modified rather than abandoned. Semaglutide side effects covers which effects pass and which need a call the same day.
Contact your clinician promptly for: severe or persistent abdominal pain, which can indicate pancreatitis or a gallbladder problem; persistent vomiting or signs of dehydration; or a lump or swelling in the neck, difficulty swallowing, or persistent hoarseness.
Not appropriate if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2; if you are pregnant, breastfeeding or trying to conceive; or with a history of pancreatitis without careful evaluation.
Because these medications slow stomach emptying, they can change how other things you take are absorbed — including oral contraceptives. Bring your full medication list.
Alcohol is worth raising with your clinician. Craving, tolerance and safety on a GLP-1 are covered in semaglutide and alcohol.
What the first months look like
Change tends to arrive in a particular order, and knowing it makes the early weeks easier to read.
Appetite usually moves first. In the first weeks many people notice the background noise around food quieten and meals end sooner. Those weeks are also when stomach side effects are most likely, so they are mostly about settling in and telling us how it is going.
The scale follows, more slowly. Weight change tends to show over months rather than weeks, and rarely in a straight line. A flat fortnight is common and is not a verdict.
Labs move last. Blood sugar, insulin and lipids are compared with your baseline at review, and those changes take months to read. The pace of all of this varies widely between people, and we do not publish an expected rate. How long semaglutide takes to work goes through it in more detail.
What we monitor while you are on it
It starts with a baseline. Before you begin, a blood panel typically covering blood sugar and insulin, lipids, kidney and liver function and thyroid, alongside weight and body composition. Your prescribing clinician reviews the labs this treatment depends on and uses them to decide whether it fits you.
Then we recheck. Labs are repeated a few months in and periodically after that, sooner if something needs watching, and each review looks at how you are tolerating treatment as well as at the numbers.
Lean mass is tracked, not assumed. We follow body composition rather than scale weight alone, because muscle is what weight loss puts at risk after 45. Semaglutide labs and monitoring explains what each marker tells us.
What happens if you stop
These medications work while you are taking them. Appetite regulation generally returns toward its previous state afterwards, and for many people weight follows. That is the mechanism, not a personal failure.
What carries forward is what you built along the way — the eating patterns, the training habit, the sleep, and the muscle you protected. Which is the honest case for treating this as a program with a plan for afterwards.
Not necessarily forever, either. Your protocol is reviewed and adjusted over time, and some members step down or stop as habits and biomarkers improve, always with their clinician.
Delivery
A once-weekly subcutaneous injection, with your regimen guided by your clinician over time.
Is it right for you?
Adults 45+ carrying weight that has not responded to lifestyle change, who want the option with the longest track record — and monitoring rather than a monthly delivery. See medical weight loss for how the program is run.
Other ways to do this
If needles are the obstacle, oral capsules are the same molecule. If a dual-pathway approach fits your metabolic picture, tirzepatide. And if your insurance already covers a branded GLP-1, look at the membership before anything else — the price shown here is an ongoing monthly cost plus periodic labs, not a one-off.
If you are in perimenopause or menopause, read hormone therapy for women alongside this. For many women that is the conversation that changes the outcome. More on how we approach it in women's health.
Clinicians who focus on weight loss
Your visit is with a licensed clinician in your state. These are the members of the medical team whose practice centers on weight loss; who you see depends on your state and availability.

Medical services are provided by licensed clinicians practicing through an independent professional entity.
Often considered alongside
Tirzepatide Injection
CompoundedA dual GLP-1 and GIP receptor agonist that supports appetite regulation and weight management.
View treatmentSemaglutide Oral Capsules
CompoundedAn oral semaglutide option for those who would rather avoid injections.
View treatmentWeight Loss Program Membership
Monthly clinical oversight and plan adjustment for members using branded GLP-1 medications.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
Semaglutide Injection, question by question
The specific questions people bring to this treatment, each answered on its own page and reviewed the same way this one is.
Compounded Semaglutide vs Wegovy: What Actually Differs
Compounded semaglutide is not Wegovy. How compounding works, what the FDA changed in 2026, and the questions to ask before filling a prescription.
ReadSemaglutide After 60: What Changes With Age
The 65+ trial data is now in, and it is good. What it shows, what it leaves out, and why muscle, bone and medication lists change the plan.
ReadSemaglutide and Heart Risk: What SELECT Showed
The one weight-loss drug with a finished cardiovascular outcomes trial in people without diabetes. Who was in SELECT, and what it found.
ReadSemaglutide and Alcohol: Craving, Tolerance and Safety
People on semaglutide often drink less without trying. What the 2025 and 2026 trials found, and the practical safety points if you do drink on it.
ReadSemaglutide for Fatty Liver (MASH): What the Approval Means
In August 2025 Wegovy became the first GLP-1 approved for a liver disease. What ESSENCE showed, and why a liver panel is the first step, not the drug.
ReadSemaglutide Side Effects: What Passes and What Needs a Call
Which semaglutide side effects come early and pass, which need a call the same day, and what the pancreas, gallbladder, thyroid and eye warnings mean.
ReadSemaglutide, Ozempic, Wegovy and Rybelsus: Three Brands Explained
One active ingredient, three brands, each with its own FDA approval. Why compounded semaglutide is none of them, why the US has no generic, and costs.
ReadHow Long Does Semaglutide Take to Work?
Appetite and food noise change first, the scale follows over months, and labs move last. The order things change, and what we check at each review.
ReadSemaglutide, Muscle Loss and Bone Density
How much of the weight lost on semaglutide can be muscle, why that matters more after 45, and the training, protein and bone checks that protect it.
ReadWhat to Eat on Semaglutide: Protein First
Smaller meals, protein first, fiber added slowly and enough fluid: a clinician-reviewed guide to eating on semaglutide, and the foods that worsen nausea.
ReadStopping Semaglutide: What the Regain Data Shows
A 2026 meta-analysis found 60% of lost weight returned within a year of stopping a GLP-1. What that means, what carries forward, and how to decide.
ReadSemaglutide and Menopause: What the Stage-by-Stage Data Shows
The first semaglutide data by menopause stage, what it can and cannot tell you, and how a GLP-1 and HRT are run together.
ReadSemaglutide and Hair Loss: Is It the Weight Loss or the Drug?
Most hair loss on semaglutide is shedding set off by fast weight loss. What the label reports, which labs to check, and when to see a dermatologist.
ReadSemaglutide Blood Work: The Labs Before and During Treatment
The labs worth having before semaglutide, when to recheck them, and what each marker tells the clinician who prescribes it.
Read
An honest word on the track record
Semaglutide has the longest clinical record of the GLP-1 medications, and that is a real advantage — but it is a record built with the FDA-approved branded product, not with a compounded preparation, so those figures do not carry across and this page quotes none of them. What we can tell you is this: semaglutide is prescribed only for eligible patients under clinical evaluation and ongoing monitoring, side effects are mostly gastrointestinal and often ease over time, and individual response varies. On the cardiovascular question, semaglutide and heart risk covers what the SELECT trial set out to test. On the liver indication, see semaglutide for fatty liver.
References
Government and professional-society sources consulted for this page.
- Semaglutide Injection — MedlinePlus (U.S. National Library of Medicine)
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration
- Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration
Frequently asked questions
It works with your body's appetite and blood-sugar signaling, alongside nutrition and strength work, as part of a monitored plan. GLP-1 is a hormone your gut already releases after eating; the medication engages that existing system. Individual response varies.
Most people describe the mental loop around food quietening rather than a surge of willpower, and meals finishing sooner because fullness arrives sooner. It is not stimulant-like. If you were expecting that, this will feel different.
No. There is no blanket BMI cutoff. Eligibility is assessed case by case on your symptoms, metabolic picture and history.
Frequently, yes — and for many women in the transition it is the more complete approach. Weight change in perimenopause is entangled with hormonal change, and addressing only one often disappoints. Both are reviewed together as part of your plan.
Some muscle loss can occur with any significant weight loss. Our protocols emphasize protein, resistance training and ongoing monitoring to support lean mass. Individual results vary. Bone deserves the same attention, since bone density can fall alongside significant weight loss, and semaglutide, muscle and bone covers how we watch both.
Then look at the Weight Loss Program Membership. You obtain the branded medication through your own pharmacy benefit and pay us only for the clinical care around it — often the better structure.
Mostly gastrointestinal, nausea most commonly, and they often ease with careful adjustment over time. Contact your clinician promptly for severe abdominal pain, persistent vomiting, or any neck lump, swallowing difficulty or persistent hoarseness. Semaglutide side effects covers which pass and which need a call.
Some people notice hair shedding on semaglutide, and it usually reflects rapid weight loss rather than a direct effect of the medication: a sharp drop in calories and protein can push more hair into its shedding phase at once, typically a few months in. It is often temporary. Protein intake and iron stores, including ferritin, are worth checking, so tell your clinician if you notice it. See semaglutide and hair loss.
Appetite is usually the first thing to change, often within the first few weeks. Weight change shows over months rather than weeks, and lab markers such as blood sugar and lipids are read against your baseline at later reviews. The pace varies widely between people, and ACT 2 Health does not publish an expected rate of loss. How long semaglutide takes to work walks through the order things change.
Anyone with a personal or family history of medullary thyroid carcinoma or MEN2; anyone pregnant, breastfeeding or trying to conceive; and anyone with a history of pancreatitis without careful evaluation.
Appetite regulation generally returns toward its previous state, and for many people weight follows. That is the mechanism rather than a personal failure. What carries forward is what you built while on it. Stopping semaglutide covers what to plan for with your clinician.
Not necessarily. Your protocol is reviewed and adjusted over time, and some members step down or stop as habits and biomarkers improve, always with their clinician.
See if Semaglutide Injection fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.